Bayer's $14.2bn loan a coup for Mizuho
Bayer, the German chemicals and pharmaceuticals firm, has signed the $14.2bn acquisition finance facility backing its purchase of Merck & Co's consumer care business.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts